Clinical Trial Update: Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of THDBH120 in Chinese adults with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• THDBH120

Snippet

Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd | Conditions: Obesity | Phase 1 | Status: COMPLETED